BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33864717)

  • 1. Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients.
    Shahrvini B; Prajapati DP; Said M; Liu J; Srinivas S; Jayaraj S; Lund VJ; DeConde AS; Lechner M; Yan CH
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1280-1282. PubMed ID: 33864717
    [No Abstract]   [Full Text] [Related]  

  • 2. Patient-reported olfactory recovery after SARS-CoV-2 infection: A 6-month follow-up study.
    Lucidi D; Molinari G; Silvestri M; De Corso E; Guaraldi G; Mussini C; Presutti L; Fernandez IJ
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1249-1252. PubMed ID: 33539667
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence and Prognostic Factors Associated with Early Recovery of Olfactory Dysfunction in COVID-19 Patients.
    Kreesaeng P; Tangbumrungtham N; Rachapattayakhom R; Roongpuvapaht B; Tanjararak K
    Ear Nose Throat J; 2024 Jun; 103(1_suppl):68S-75S. PubMed ID: 37743845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smell Status in Children Infected with SARS-CoV-2.
    Rusetsky Y; Meytel I; Mokoyan Z; Fisenko A; Babayan A; Malyavina U
    Laryngoscope; 2021 Aug; 131(8):E2475-E2480. PubMed ID: 33443298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis.
    Purja S; Shin H; Lee JY; Kim E
    Arch Pharm Res; 2021 Jul; 44(7):725-740. PubMed ID: 34302637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anosmia: A Clinical Indicator of COVID-19 Reinfection.
    Jain A; Kaur J; Rai AK; Pandey AK
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):180S-181S. PubMed ID: 33295221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smell dysfunction in COVID-19 patients: More than a yes-no question.
    Lima MA; Silva MTT; Oliveira RV; Soares CN; Takano CL; Azevedo AE; Moraes RL; Rezende RB; Chagas IT; Espíndola O; Leite AC; Araujo A
    J Neurol Sci; 2020 Nov; 418():117107. PubMed ID: 32866813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of Smell and Taste in Asymptomatic and Symptomatic COVID-19 Patients in Sicily, Italy.
    Bianco MR; Modica DM; Drago GD; Azzolina A; Mattina G; De Natale M; Rossi G; Amata M; Canzoneri G; Manganaro G; Di Gregorio F; Russo R; Pricoco S; Saita V; Allegra E
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):182S-185S. PubMed ID: 33350319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.
    Mendes Paranhos AC; Nazareth Dias ÁR; Machado da Silva LC; Vieira Hennemann Koury G; de Jesus Sousa E; Cerasi AJ; Souza GS; Simões Quaresma JA; Magno Falcão LF
    JAMA Netw Open; 2022 Sep; 5(9):e2230637. PubMed ID: 36074464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory function and viral recovery in COVID-19.
    Mazzoli M; Molinari MA; Tondelli M; Giovannini G; Ricceri R; Ciolli L; Picchetto L; Meletti S
    Brain Behav; 2021 Mar; 11(3):e02006. PubMed ID: 33465295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19, cilia, and smell.
    Li W; Li M; Ou G
    FEBS J; 2020 Sep; 287(17):3672-3676. PubMed ID: 32692465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection.
    Galluzzi F; Rossi V; Bosetti C; Garavello W
    Neuroepidemiology; 2021; 55(2):154-161. PubMed ID: 33794531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychophysical evaluation of chemosensory functions 5 weeks after olfactory loss due to COVID-19: a prospective cohort study on 72 patients.
    Le Bon SD; Pisarski N; Verbeke J; Prunier L; Cavelier G; Thill MP; Rodriguez A; Dequanter D; Lechien JR; Le Bon O; Hummel T; Horoi M
    Eur Arch Otorhinolaryngol; 2021 Jan; 278(1):101-108. PubMed ID: 32754871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible Taste Loss in a COVID-19 Patient With Preexisting Chronic Smell Impairment.
    Klein H; Karni N; Israel S; Gross M; Muszkat M; Niv MY
    J Investig Med High Impact Case Rep; 2021; 9():2324709621990765. PubMed ID: 33535814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long COVID: Does It Exist? What Is It? We Can We Do For Sufferers?
    Hoffer EP
    Am J Med; 2021 Nov; 134(11):1310-1311. PubMed ID: 34237305
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-acute neurological consequences of COVID-19: an unequal burden.
    Nolen LT; Mukerji SS; Mejia NI
    Nat Med; 2022 Jan; 28(1):20-23. PubMed ID: 35039657
    [No Abstract]   [Full Text] [Related]  

  • 18. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.
    D'Ascanio L; Pandolfini M; Cingolani C; Latini G; Gradoni P; Capalbo M; Frausini G; Maranzano M; Brenner MJ; Di Stadio A
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):82-86. PubMed ID: 32662745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of patient recognition of coronavirus disease 2019 (COVID-19)-associated olfactory loss and recovery: a longitudinal study.
    Prajapati DP; Shahrvini B; Said M; Srinivas S; DeConde AS; Yan CH
    Int Forum Allergy Rhinol; 2021 Nov; 11(11):1529-1537. PubMed ID: 34096193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory disorder in patients infected with SARS-CoV-2.
    Yen YF; Lai HH; Chan SY; Su VY; Chiu TF; Huang CY; Hung CC; Kuo TL; Lee YL; Chu D
    J Microbiol Immunol Infect; 2021 Oct; 54(5):992-996. PubMed ID: 32859529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.